Proteomic Profiling of Native Unpassaged and Culture-Expanded Mesenchymal Stromal Cells (MSC)

Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers

(2017) Y Liu et al.   ONCOGENE

CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia

(2017) Shihong Lu et al.   Stem Cell Research & Therapy

Standardization of Good Manufacturing Practice–compliant production of bone marrow–derived human mesenchymal stromal cells for immunotherapeutic applications

(2015) Patrick Wuchter et al.   CYTOTHERAPY

Human bone marrow stromal cell confluence: effects on cell characteristics and methods of assessment

(2015) Jiaqiang Ren et al.   CYTOTHERAPY

Placenta-derived mesenchymal stem cells possess better immunoregulatory properties compared to their cord-derived counterparts–a paired sample study

(2015) Manasi D. Talwadekar et al.   Scientific Reports

MSC-Based Product Characterization for Clinical Trials: An FDA Perspective

(2014) Michael Mendicino et al.   Cell Stem Cell

Expression and biological function of programmed death ligands in human placenta mesenchymal stem cells

(2013) Guoyan Wang et al.   CELL BIOLOGY INTERNATIONAL

CD106 Identifies a Subpopulation of Mesenchymal Stem Cells with Unique Immunomodulatory Properties

(2013) Zhou Xin Yang et al.   PLoS One

Activation of Human Mesenchymal Stem Cells Impacts Their Therapeutic Abilities in Lung Injury by Increasing Interleukin (IL)-10 and IL-1RN Levels

(2013) Martha L. Bustos et al.   Stem Cells Translational Medicine

Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis

(2012) Kentaro Akiyama et al.   Cell Stem Cell

Adipose-derived stem cells induced dendritic cells undergo tolerance and inhibit Th1 polarization

(2012) Wei Peng et al.   CELLULAR IMMUNOLOGY

Mesenchymal markers on human adipose stem/progenitor cells

(2012) Ludovic Zimmerlin et al.   CYTOMETRY PART A

PD-1 is a novel regulator of human B-cell activation

(2012) Marie-Laure Thibult et al.   INTERNATIONAL IMMUNOLOGY

Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials

(2012) Manoj M. Lalu et al.   PLoS One

Mesenchymal Stem Cells: Mechanisms of Inflammation

(2011) Nora G. Singer et al.   Annual Review of Pathology-Mechanisms of Disease

Development and validation of a procedure to isolate viable bone marrow cells from the vertebrae of cadaveric organ donors for composite organ grafting

(2011) Vijay S. Gorantla et al.   CYTOTHERAPY

Mesenchymal Stem/Stromal Cells (MSCs): Role as Guardians of Inflammation

(2011) Darwin J Prockop et al.   MOLECULAR THERAPY

The Cell Surface Proteome of Human Mesenchymal Stromal Cells

(2011) Christian Niehage et al.   PLoS One

Clinical implementation of a procedure to prepare bone marrow cells from cadaveric vertebral bodies

(2011) Albert D Donnenberg et al.   Regenerative Medicine

Establishment of a Mesenchymal Stem Cell Bank

(2011) Khushnuma Cooper et al.   Stem Cells International

Markers Distinguishing Mesenchymal Stem Cells from Fibroblasts Are Downregulated with Passaging

(2010) Svetlana Halfon et al.   STEM CELLS AND DEVELOPMENT

Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells

(2009) Ekaterina Ivanova-Todorova et al.   IMMUNOLOGY LETTERS

Cytotoxicity Mediated by the Fas Ligand (FasL)-activated Apoptotic Pathway in Stem Cells

(2009) Julia Mazar et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction

(2009) Joshua M. Hare et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs

(2008) Mihaela Crisan et al.   Cell Stem Cell